News and Trends 21 Jul 2016
Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials
Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its platform for novel viral vectors, which promises to yield better vaccines for infections and cancer. Based in Vienna, Hookipa was founded in 2011 and is developing a new class of immunotherapies. Its strategy for novel […]